Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Humana and Greater Good Health Expand Access to Primary Care in Montana with Opening of Senior-focused Primary Care Clinics: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana and Greater Good Health Expand Access to Primary Care in Montana with Opening of Senior-focused Primary Care Clinics


Humana, a leading health and well-being company, and Greater Good Health, a healthcare organization expanding access to primary care for seniors through a nurse practitioner-led value-based care

Premier, Inc. Declares Quarterly Cash Dividend: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common

Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2023.



Third Quarter 2023 Financial Highlights:




  • Revenue grew 27% versus the same

Acadia Healthcare Announces Date for Third Quarter 2023 Earnings Release: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Announces Date for Third Quarter 2023 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2023 results on Thursday, November 2, 2023, after the close of the market. Acadia will conduct

Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical drug discovery and development, today reported financial results for its

Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance:
Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Owens & Minor Announces Third Quarter 2023 Earnings Release Date and Conference Call: https://mms.businesswire.com/media/20211103005246/en/922805/5/O%26M_LogoTM_hi-res.jpg
Owens & Minor Announces Third Quarter 2023 Earnings Release Date and Conference Call


Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange.



The Company

Agilent to Announce Fourth-Quarter Fiscal Year 2023 Financial Results Nov. 20:
Agilent to Announce Fourth-Quarter Fiscal Year 2023 Financial Results Nov. 20


Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2023 after the stock market closes on Monday, Nov. 20. In addition, the company will host a

Owens & Minor Announces Third Quarter 2023 Earnings Release Date and Conference Call: https://mms.businesswire.com/media/20211103005246/en/922805/5/O%26M_LogoTM_hi-res.jpg
Owens & Minor Announces Third Quarter 2023 Earnings Release Date and Conference Call


Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange.



The Company

Agilent’s Net-Zero Emissions Targets Approved by the Science Based Targets InitiativePhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
Agilent’s Net-Zero Emissions Targets Approved by the Science Based Targets Initiative


Agilent Technologies Inc. (NYSE: A) today announced the company’s near and long-term targets for reaching net-zero greenhouse gas emissions have been approved by the Science Based Targets

STAAR Surgical to Report Third Quarter Results on November 1, 2023: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report Third Quarter Results on November 1, 2023


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the third quarter

Humana’s Medicare Advantage Footprint in New Jersey Complete: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana’s Medicare Advantage Footprint in New Jersey Complete


Leading health and well-being company Humana Inc. (NYSE: HUM) is expanding its health plans to Middlesex County, widening the company’s Medicare Advantage footprint to 100% of the state.



For the

STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL): https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer®

QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report fourth quarter and fiscal 2023 financial results after the market close on Wednesday, October 25

Chemed To Report Third-Quarter 2023 Earnings October 25, Related Conference Call To Be Held On October 26:
Chemed To Report Third-Quarter 2023 Earnings October 25, Related Conference Call To Be Held On October 26


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2023, on Wednesday, October 25, 2023, following the close of trading

Premier, Inc. to Report Fiscal 2024 First-Quarter Results and Host Conference Call on November 7, 2023: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. to Report Fiscal 2024 First-Quarter Results and Host Conference Call on November 7, 2023


Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2024 first quarter on Tuesday, November 7, 2023, at approximately 6:30 a.m. ET. The company will

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2023 financial

NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for

Humana and Denver Health Sign Agreement to Expand Humana’s Medicare Advantage Provider Network in the Denver Area: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana and Denver Health Sign Agreement to Expand Humana’s Medicare Advantage Provider Network in the Denver Area


Humana, a leading health and well-being company, and Denver Health, a comprehensive health and hospital system, have entered into an agreement that broadens access to care for Humana Medicare

Humana #1 in Customer Satisfaction Among Medicare Advantage Plans in Florida: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana #1 in Customer Satisfaction Among Medicare Advantage Plans in Florida


Leading health and well-being company Humana Inc. (NYSE: HUM) is ranked #1 in Florida in the J.D. Power ranking of Medicare Advantage Member Health Plans. Humana, the largest Medicare Advantage

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today new clinical study outcomes that further demonstrate the benefits

Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, October 26, 2023. Management will hold a conference call

QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine

PINC AI™ and Fortune Name the Nation’s 100 Top Hospitals®: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
PINC AI™ and Fortune Name the Nation’s 100 Top Hospitals®


PINC AI, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 100 top hospitals. The full list of recognized hospitals was published in an exclusive